表观遗传阅读器含溴结构域蛋白2通过与ETS原癌基因1相互作用介导胆管细胞衰老
该研究探讨含溴结构域和超末端结构域(BET)蛋白与ETS原癌基因1(ETS1)相互作用驱动胆管细胞衰老的机制。在PSC患者肝组织、小鼠PSC模型及体外衰老胆管细胞中,BRD2和BRD4蛋白表达增加,BET抑制可减少衰老标志物和纤维炎症分泌组,并在小鼠模型中减轻纤维化。数据提示BRD2是衰老胆管细胞表型的关键介质和PSC的潜在治疗靶点。
要点
- PSC患者和小鼠PSC模型胆管细胞BRD2和BRD4蛋白较无病对照增加约5倍。
- 体外衰老胆管细胞BRD2和BRD4增加约2倍,PSC患者来源胆管细胞BRD2增加约2倍。
- BET抑制在体外减少衰老标志物和纤维炎症分泌组,在小鼠模型中减轻衰老、纤维炎症基因表达和纤维化。
核心结论
- 数据提示BRD2是衰老胆管细胞表型的关键介质,并可能是PSC患者的潜在治疗靶点。
研究设计与样本
- 研究采用PSC患者肝组织、小鼠PSC模型、正常人胆管细胞(NHC)、实验诱导衰老的正常人胆管细胞(NHCsen)和PSC患者来源胆管细胞(PSCDC),以及3,5-二乙氧羰基-1,4-二氢可力丁喂养和Mdr2-/-小鼠模型。
主要发现
- PSC患者和小鼠PSC模型胆管细胞BRD2和BRD4蛋白较无病对照增加约5倍。
- NHCsen的BRD2和BRD4较NHC增加约2倍,PSCDC的BRD2较NHC增加约2倍。
- BET抑制减少NHCsen和PSCDC的衰老标志物并抑制纤维炎症分泌组。
- NHCsen中ETS1与BRD2相互作用,BRD2敲低减少NHCsen的p21表达。
- BET抑制剂在3,5-二乙氧羰基-1,4-二氢可力丁喂养和Mdr2-/-小鼠模型中减少衰老、纤维炎症基因表达和纤维化。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We reported that cholangiocyte senescence, regulated by the transcription factor ETS proto-oncogene 1 (ETS1), is a pathogenic feature of primary sclerosing cholangitis (PSC). Furthermore, histone 3 lysine 27 is acetylated at senescence-associated loci. The epigenetic readers, bromodomain and extra-terminal domain (BET) proteins, bind acetylated histones, recruit transcription factors, and drive gene expression. Thus, we tested the hypothesis that BET proteins interact with ETS1 to drive gene expression and cholangiocyte senescence. METHODS: We performed immunofluorescence for BET proteins (BRD2 and 4) in liver tissue from liver tissue from PSC patients and a mouse PSC model. Using normal human cholangiocytes (NHCs), NHCs experimentally induced to senescence (NHCsen), and PSC patient-derived cholangiocytes (PSCDCs), we assessed senescence, fibroinflammatory secretome, and apoptosis after BET inhibition or RNA interference depletion. We assessed BET interaction with ETS1 in NHCsen and tissues from PSC patient, and the effects of BET inhibitors on liver fibrosis, senescence, and inflammatory gene expression in mouse models. RESULTS: Tissue from patients with PSC and a mouse PSC model exhibited increased cholangiocyte BRD2 and 4 protein (∼5×) compared with controls without disease. NHCsen exhibited increased BRD2 and 4 (∼2×), whereas PSCDCs exhibited increased BRD2 protein (∼2×) relative to NHC. BET inhibition in NHCsen and PSCDCs reduced senescence markers and inhibited the fibroinflammatory secretome. ETS1 interacted with BRD2 in NHCsen, and BRD2 depletion diminished NHCsen p21 expression. BET inhibitors reduced senescence, fibroinflammatory gene expression, and fibrosis in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine-fed and Mdr2-/- mouse models. CONCLUSION: Our data suggest that BRD2 is an essential mediator of the senescent cholangiocyte phenotype and is a potential therapeutic target for patients with PSC.
引用
- Kang JH, Splinter PL, Trussoni CE, et al. The Epigenetic Reader, Bromodomain Containing 2, Mediates Cholangiocyte Senescence via Interaction With ETS Proto-Oncogene 1. Gastroenterology. 2023. PMID: 37059338. doi:10.1053/j.gastro.2023.03.235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。